Atropisomeric Chiral Diiododienes (Z,Z)-2,3-Di(1-iodoalkylidene)tetralins : Synthesis, Enantiomeric Resolution, and Application in Asymmetric Catalysis by Ogasawara, Masamichi et al.
Atropisomeric Chiral Diiododienes (Z,Z)-2,3-Di(1-
iodoalkylidene)tetralins: Synthesis, Enantiomeric Resolution, and 
Application in Asymmetric Catalysis 
Masamichi Ogasawara,*,†,‡ Hirotaka Sasa,§ Hao Hu,†,‡ Yuta Amano,§ Hikaru Nakajima,‡ Naoko Takenaga,‖ Ki-
yohiko Nakajima,⊥ Yasuyuki Kita,¶ Tamotsu Takahashi,‡ and Toshifumi Dohi*,§ 
†Department of Natural Science, Graduate School of Science and Technology, Tokushima University, Tokushima 770-8506, Japan 
‡Institute for Catalysis and Graduate School of Life Science, Hokkaido University, Kita-ku, Sapporo 001-0021, Japan 
§College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-8577, Japan ‖Faculty of Pharmacy, Meijo University, 150 Yagotoyama, Tempaku-ku, Nagoya, 468-8503, Japan ⊥Department of Chemistry, Aichi University of Education, Igaya, Kariya, Aichi, 448-8542, Japan 
¶Research Organization of Science and Technology, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-8577, Japan 
Supporting Information Placeholder 
ABSTRACT: The C2-symmetric tetralin-fused 1,4-diiodo-1,3-butadiene derivatives, (Z,Z)-2,3-di(1-iodoalkylidene)tetralin 1a-c, are atro-
pisomeric and can be resolved into the two persistent axially chiral enantiomers by HPLC on a chiral stationary phase. The enantiomerically 
pure compounds can serve as chiral organocatalysts for dearomatizing spirolactonization to show good performances in up to 73 % ee. 
"Atropisomerism" is the phenomenon of chirality by virtue of re-
stricted rotation about a single bond.1 The first experimental obser-
vation of atropisomerism was reported by Christie and Kenner in 
1922 in a 2,2',6,6'-tetra-substituted biphenyl.2 Since then, various 
atropisomeric biaryl compounds have been prepared and their 
single-enantiomeric counterparts have been utilized in a wide range 
of asymmetric reactions as useful chiral scaffolds.3 Atropisomeric 
systems other than biarys, which are often referred to as "non-biaryl 
atropisomers",4 include aryl amides,5 diaryl ethers,6 etc.,7 and these 
have been rapidly developing in the last few decades. 
Possibilities of alkenyl-alkenyl atropisomerism in 1,3-dienes were 
pointed out in the 1950s,8,9 however, such enantiomerically resolv-
able dienes are rare.10 The energy barrier to rotation about the C2-
C3 bond in a 1,3-diene is generally low, and thus majority of atro-
pisomeric dienes reported so far show slow C2-C3 bond rotation 
and racemize at and above ambient temperature.8,10,11 For example, 
optically active dicarboxylic acid A racemizes completely within 22 
min at room temperature.9 The incorporation of a fused cyclic 
structure at the C2-C3 bond of a 1,3-diene increases the conforma-
tional rigidity of the molecule, and bulky substituents on the "inner" 
sides of the dienic 1- and 4-positions force the diene to adopt a 
nonplanar chiral conformation. While these structural modifica-
tions increase the racemization barriers in atropisomeric 1,3-dienes, 
cyclopentane-fused (Z,Z)-1-silyl-4-stannyl-1,3-diene B12 and cy-
clohexane- or tetralin-fused (Z,Z)-1,4-bis(phosphino)-1,3-dienes 
C13 and D14 still show slow interconversion of the respective atro-
pisomeric enantiomers in solution. Recently we disclosed that 
closely related (Z,Z)-1,4-bis(phosphinyl)-1,3-diene E could be 
resolved into the two persistent enantiomers, which did not race-
mize even at 135 °C.14 Enantiomerically pure E thus obtained was 
applied as a Lewis base chiral organocatalyst in the asymmetric 
allylation of aldehydes with allylsilanes to show excellent enantiose-
lectivity.14 These observations have indicated the potential useful-
ness of the atropisomeric diene systems in asymmetric synthesis. 
In this report, we would like to describe synthesis and characteri-
zation of novel C2-symmetric conformationally rigid atropisomeric 
chiral diiododienes 1.15 Preformed racemic diiododienes 1a-c were 
resolved by HPLC on a chiral stationary phase, and single-
enantiomeric 1a-c thus obtained were applied in the asymmetric 
dearomatizing spirolactonization as chiral organocatalysts to show 
good enantioselectivity in up to 73% ee. 
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Figure 1. Atropisomerism in 1,3-dienes. 
Treatment of 1,2-bis(4,4-dimethyl-2-pentynyl)benzene (2a) 
with Cp2ZrCl2/Mg16 generated the corresponding zirconacyclo-
pentadiene derivative 3a in situ, and subsequently its iodolysis in 
the presence of CuCl followed by chromatographic purification 
gave 1a in 40% yield as a colorless crystalline solid. Protonolysis of 
3a afforded homologous hydrocarbon 4a in 45% yield as well 
(Scheme 1). In the same way, methyl-substituted 1b and trime-
thylsilyl-substituted 1c17 were prepared in 68% and 41% yields, 
respectively. 
Scheme 1. Synthesis and Enantiomeric Resolution of Atrop-
isomeric Chiral Diiododienes 1 
 
In the 1H-NMR spectrum of 1a recorded in CDCl3, the meth-
ylene hydrogens at the 1- and 4-positions of the tetralin skeleton 
(Ha and Hb in Figure 2 (a)) were detected at δ 3.58 and 4.23 (2JHH = 
16.5 Hz) as a pair of well-resolved AB doublets. This observation 
implies that the two sterically demanding iodo-substituents in 1a 
interact with each other, which prevents the molecule from taking 
the coplanar conformation. And thus, the diene-based atropisomer-
ic axial chirality is induced in 1a, and the two hydrogens in each 
CH2 group are diastereotopic. The AB pattern in the 1H-NMR 
spectrum was retained even at 140 °C in CDCl2CDCl2 and the 
signals showed no apparent broadening at this temperature. The 
NMR behavior indicated that 1a showed no racemization or the 
racemization was much slower than the NMR time-scale. Methyl- 
or trimethylsilyl-substituted diiododienes, 1b and 1c, showed simi-
lar 1H-NMR behavior as well. On the other hand, the two meth-
ylene hydrogens in closely related "hydro"-derivative 4a are equiva-
lent and detected as a sharp singlet in its 1H-NMR spectrum (Fig-
ure 2 (b)) due to rapid rotation of the C2-C3 bond or planarity of 
the diene moiety (i.e., 4a is achiral). 
 
Figure 2. The 1H-NMR spectra of (a) 1a and (b) 4a in the ben-
zylic/olefinic region at 400 MHz in CDCl3 at 23 °C. 
The 1H-NMR behavior of 1a postulates that the compound is at-
ropisomeric and the respective enantiomers may be separated as 
optically active species. Indeed, 1a could be resolved into the two 
atropenantiomers in practically enantiomerically pure forms 
(>99.9% ee) by HPLC on a chiral stationary phase column (Daicel 
Chiralcel OD-H) using hexane as an eluent (Figure 3). Diiodo-
diene 1a displayed remarkable conformational rigidity with respect 
to the dienic axial chirality. The fast-eluting enantiomer of 1a on an 
OD-H column is dextrorotatory ([a]D21 = +63.6 (c 0.33, CHCl3)). 
The resolved single-enantiomeric sample of (+)-1a was dissolved 
in mesitylene and heated at 150 °C for 12 h in the dark. After this 
time, the chiral HPLC analysis of (+)-1a showed no signs of race-
mization. On the basis of an assumed detection limit of 0.1% ee for 
this HPLC analysis, we estimated the lower limit of the activation 
energy of the atropisomeric racemization of 1a at 150 °C to be 
ΔG‡(423 K) ≥ 39.8 kcal/mol. This energy barrier in 1a is high 
enough to prevent the compound from racemization, and indeed, 
the resolved sample of (–)-1a (>99.9% ee) kept at –30 °C for more 
than a year has retained its enantiomeric homogeneity. 
 
Figure 3. HPLC trace for rac-1a on a Daicel Chiralcel OD-H col-
umn (i.d., 4.6 mm; eluent, hexane; flow rate, 1.0 mL/min). 
Both diiododienes 1b and 1c could be resolved into the respec-
tive "persistent" enantiomers by HPLC on a chiral stationary phase 
column as well (Daicel Chiralpak IB for 1b; Chiralpak IA for 1c. 
See Supporting Information for details). 
The presence of the sterically demanding iodo-substituents in 1 
is crucial for the conformational rigidity of the molecules. Treat-
ment of (M)-(+)-1a (>99.9% ee) with tBuLi (4.5 equiv to 1a) in 
THF at –78 °C generated dilithio-derivative 5a in situ (confirmed 
by its protonolysis giving 4a), and the subsequent reaction of 5a 
with excess iodine at –78 °C re-generated 1a in 57% yield. The 
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 chiral HPLC analysis of recovered 1a revealed that the compound 
was nearly racemic (<0.5% ee). Considering the conformational 
rigidity of 1a (vide supra), the racemization could be attributed to 
the conformational fluxionality of 5a which is with the much more 
compact lithio-substituents instead of the two iodo-substituents in 
1a. These observations are consistent with the reported behavior of 
binaphthyl derivatives; while axially chiral 2,2'-diiodo-1,1'-
binaphthyl can be resolved into the respective "persistent" atrop-
enantiomers, the corresponding 2,2'-dilithio-derivative racemizes 
easily.18 
Scheme 2. Lithiation of (M)-(+)-1a and Iodolysis Forming rac-
1a. 
 
Dextrorotatory 1a was recrystallized from cold pentane yielding 
colorless needles suitable for X-ray analysis. The Flack parameter 
was determined to be –0.05(3) for the structure shown in Figure 4, 
and the absolute configuration of (+)-1a is unambiguously as-
signed to be (M) (see Supporting Information for details). As 
shown in Figure 4, the array of the six atoms I(1)-C(1)-C(2)-
C(11)-C(12)-I(2) constructs a characteristic helical motif in (+)-
1a. The two iodine atoms, I(1) and I(2), considerably interact with 
each other, which should be a major factor preventing 1a from 
racemization. 
 
Figure 4. Ball-and-stick drawing of the single-crystal X-ray struc-
ture of (M)-(+)-1a with selected atom numbering. 
We next investigated the potential of novel atropisomeric diio-
dodienes (+)-1a-c as chiral organocatalysts in the asymmetric 
dearomatizing spirolactonization of 3-(1-hydroxy-2-
naphthyl)propionic acid 6,19,20 and the results are summarized in 
Table 1. The reaction is mediated by a hypervalent iodine(III) 
species,21,22 and the oxidative cyclization creates a chiral spiro-
carbon atom in lactone 7. 
Under the conditions shown in entry 1, i.e. in the presence of 
"wet" m-chloroperbenzoic acid (mCPBA containing 31% H2O; 1.3 
equiv to 6) and (M)-(+)-1a (10 mol %) in dichloromethane at 0 °C, 
the oxidative cyclization of substrate 6 proceeded smoothly to give 
desired spirolactone 7 in 52% yield with 47% ee. Whereas the cata-
lytically active hypervalent iodine(III) species23 had low solubility 
in dichloromethane, conducting the reaction at lower concentra-
tion improved both chemical yield and enantioselectivity slightly 
(entry 2). While spirolactone 7 obtained using (+)-1a was levoro-
tatory, that is with the (S)-stereogenic carbon atom, the reaction 
catalyzed by (+)-1b afforded dextrorotatory (R)-7 in 45% ee and 
47% yield (entry 3). Both 1a and 1b decomposed slowly at room 
temperature in the presence of wet mCPBA, and thus, they could 
not be recovered from the reaction mixture. On the other hand, 
Me3Si-substituted counterpart 1c showed better stability under the 
same conditions, and ca. 50% of 1c was recovered from the catalyt-
ic reaction mixture. Due probably to the higher robustness, (+)-1c 
showed the better catalytic activity than 1a and 1b (entries 4-6). In 
addition, 1c was found to be the most enantioselective among the 
three diiododienes. The reaction catalyzed by (+)-1c afforded (S)-
7 in 64% ee (entry 4). It was found that addition of acetic acid (6 
equiv to 6) was effective for preventing precipitation of the reactive 
hypervalent iodine(III) species, and (S)-7 was obtained in 77% 
yield and in 69% ee (entry 5). Lowering the reaction temperature 
to –20 °C further improved the results giving (S)-7 of 73% ee in 
85% yield under the optimized conditions (entry 6). It should be 
mentioned that, to the best of our knowledge, diiododienes 1 are 
the first examples of "non-aryl" organic iodides serving for the l3-
iodane-mediated asymmetric hypervalent iodine organocatalysis.23 
Table 1. Asymmetric Dearomatizing Spirolactonization of 6 
Catalyzed by C2-Symmetric Atropisomeric Diiododienes 1a 
 
entry cat. additive temp time yieldb % eec 
1d (+)-1a none 0 °C 16 h 52% 47 (S) 
2 (+)-1a none 0 °C 20 h 57% 52 (S) 
3 (+)-1b none 0 °C 20 h 47% 45 (R) 
4 (+)-1c none 0 °C 20 h 60% 64 (S) 
5 (+)-1c AcOHe 0 °C 15 h 77% 69 (S) 
6 (+)-1c AcOHe –20 °C 39 h 85% 73 (S) 
a The reaction was conducted with 10 mol % of diiododiene 1 at 
0.005 M concentration of substrate 6. b Isolated yield by silica gel 
chromatography. c Determined by HPLC analysis on a chiral stationary 
phase (Daicel Chiralcel OD-H). The absolute configuration of 7 in 
parentheses. d 0.01 M concentration of substrate 6. e 6 equiv to 6. 
In summary, we have found out that C2-symmetric tetralin-fused 
1,4-diiodo-1,3-butadiene derivatives, (Z,Z)-2,3-di(1-
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 iodoalkylidene)tetralin 1a-c, are atropisomeric and conformation-
ally persistent. After the enantiomeric resolution of the preformed 
racemates, the single-enantiomeric compounds were applied as 
chiral organocatalysts in the oxidative spirolactonization of 6 to 
show good performances with up to 73 % ee. 
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